Racial and ethnic minority groups are at increased risk of contracting and dying from COVID-19. Historically, these groups have been less likely to be included in clinical trials for disease treatment.
The Color of COVID: Will Vaccine Trials Reflect America’s Diversity? discusses growing demands of drug makers and investigators to ensure that vaccine trials reflect the entire community.
Why Are More Black Americans Dying of COVID-19? looks at some of the underlying reasons for the racial disparities made visible during the COVID-19 pandemic.